ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Toshiharu Shinoka
Gregor Zund
Takuya Miura
John E. Mayer, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinoka, T.
Right arrow Articles by Mayer, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinoka, T.
Right arrow Articles by Mayer, J. E., Jr

Ann Thorac Surg 1995;60:S513-S516
© 1995 The Society of Thoracic Surgeons

Articles

Tissue engineering heart valves: Valve leaflet replacement study in a lamb model

MD Toshiharu Shinoka, MD Christpher K. Breuer, MD Ronn E. Tanel, MD Gregor Zund, MD Takuya Miura, PhD Peter X. Ma, PhD Robert Langer, MD Joseph P. Vacanti, MD John E. Mayer, Jr*

Departments of Cardiovascular Surgery and Surgery, Children's Hospital, Boston, and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

* Address reprint requests to Dr Mayer, Department of Cardiovascular Surgery, Children's Hospital, 300 Longwood Ave, Boston, MA 02115.
*

Background: Valve replacements using either bioprosthetic or mechanical valves have the disadvantage that these structures are unable to grow, repair, or remodel and are both thrombogenic and susceptible to infection. These characteristics have significantly limited their durability and longevity. In an attempt to begin to overcome these shortcomings, we have tested the feasibility of constructing heart valve leaflets in lambs by seeding a synthetic polyglycolic acid fiber matrix in vitro with fibroblasts and endothelial cells.

Methods: Mixed cell populations of endothelial cells and fibroblasts were isolated from explanted ovine arteries. Endothelial cells were selectively labeled with an acetylated low-density lipoprotein marker and separated from the fibroblasts using a fluorescent activated cell sorter. A synthetic biodegradable scaffold constructed from polyglycolic acid fibers was seeded with fibroblasts, which grew to form a tissue-like sheet. This tissue was subsequently seeded with endothelial cells, which formed a cellular monolayer coating around the leaflet. Using these constructs, autologous (n = 3) and allogenic (n = 4) tissue engineered leaflets were implanted in 7 animals. In each animal the right posterior leaflet of the pulmonary valve was resected and replaced with an engineered valve leaflet.

Results: All animals survived the procedure. Postoperative echocardiography demonstrated no evidence of stenosis and trivial pulmonary regurgitation in the autografts and moderate regurgitation in the allogenic valves. Collagen analysis of the constructs showed development of an extracellular matrix. Histologic evaluation of the constructs demonstrated appropriate cellular architecture.

Conclusions: This preliminary experiment showed that a tissue engineered valve leaflet constructed from its cellular components can function in the pulmonary valve position. Tissue engineering of a heart valve leaflet is feasible, and these preliminary studies suggest that autograft tissue will probably be superior to allogenic tissue.




This article has been cited by other articles:


Home page
 Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in MedicineHome page
H.-Y. S. Huang, B. N. Balhouse, and S. Huang
Application of simple biomechanical and biochemical tests to heart valve leaflets: Implications for heart valve characterization and tissue engineering
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, November 1, 2012; 226(11): 868 - 876.
[Abstract] [PDF]

Home page
 Asian Cardiovascular and Thoracic AnnalsHome page
D.-E. Zhao, R.-B. Li, W.-Y. Liu, G. Wang, S.-Q. Yu, C.-W. Zhang, W.-S. Chen, and G.-X. Zhou
Tissue-Engineered Heart Valve on Acellular Aortic Valve Scaffold: In-Vivo Study
Asian Cardiovascular and Thoracic Annals, June 1, 2003; 11(2): 153 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
Q. Ye, G. Zund, P. Benedikt, S. Jockenhoevel, S. P. Hoerstrup, S. Sakyama, J. A. Hubbell, and M. Turina
Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering
Eur J Cardiothorac Surg, May 1, 2000; 17(5): 587 - 591.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
Q. Ye, G. Zund, S. Jockenhoevel, S. P. Hoerstrup, A. Schoeberlein, J. Grunenfelder, and M. Turina
Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue
Eur J Cardiothorac Surg, April 1, 2000; 17(4): 449 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
G. Zund, Q. Ye, S. P. Hoerstrup, A. Schoeberlein, A. C. Schmid, J. Grunenfelder, P. Vogt, and M. Turina
Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes
Eur J Cardiothorac Surg, April 1, 1999; 15(4): 519 - 524.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.